If you have been reading about hGH fragment and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-01-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Fragment analog of human growth hormone |
| Sequence basis | hGH 176–191 region | Modified C-terminal fragment |
| Common synonyms | AOD-9604; AOD9604; hGH fragment | Research and trade names vary |
| Regulatory status | Not approved as a drug | Prohibited in competitive sport |
| Research code | AOD9604 | Used in scientific and patent literature |
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
== Reactivity == The high acidity of the imido N-H is the result of the pair of flanking electron-withdrawing carbonyl groups. Both sodium phthalimide and potassium phthalimide are well known. The latter can be made by reaction of phthalimide with potassium carbonate or potassium hydroxide.. The potassium salt is used in the Gabriel synthesis of primary amines.
=== Withdrawal symptoms === Following abrupt or rapid discontinuation of pregabalin, some people reported symptoms suggestive of physical dependence. The FDA determined that the substance dependence profile of pregabalin, as measured by a personal physical withdrawal checklist, was quantitatively less than benzodiazepines. Even people who have discontinued short-term use of pregabalin have experienced withdrawal symptoms, including insomnia, headache, heart palpitations, nausea, anxiety, diarrhea, flu-like symptoms, major depression, pain, seizures, excessive sweating, muscle twitching, and dizziness. A tapered discontinuation is recommended to reduce the chances of withdrawal symptoms. Lyrica's US package insert recommends a taper period of at least one week. Best Practice Advocacy Centre New Zealand and NHS Somerset recommend a much slower withdrawal.
==== European Union ==== In February 2016, orphan designation (EU/3/16/1615) was granted by the European Commission to Gilead Sciences International Ltd, United Kingdom, for remdesivir for the treatment of Ebola virus disease. In April 2020, the European Medicines Agency (EMA) provided recommendations on compassionate use of remdesivir for COVID‑19 in the EU. In May 2020, the Committee for Medicinal Products for Human Use (CHMP) of the EMA recommended expanding the compassionate use of remdesivir to those not on mechanical ventilation. In addition to those undergoing invasive mechanical ventilation, the compassionate use recommendations cover the treatment of hospitalized individuals requiring supplemental oxygen, non-invasive ventilation, high-flow oxygen devices or ECMO (extracorporeal membrane oxygenation). The updated recommendations were based on preliminary results from the NIAID-ACTT study, which suggested a beneficial effect of remdesivir in the treatment of hospitalized individuals with severe COVID‑19. In addition, a treatment duration of five days was introduced alongside the longer ten-day course, based on preliminary results from another study (GS-US-540-5773) suggesting that for those not requiring mechanical ventilation or ECMO, the treatment course may be shortened from ten to five days without any loss of efficacy. Individuals who receive a five-day treatment course but do not show clinical improvement will be eligible to continue receiving remdesivir for an additional five days.
==== Moisture passageways ==== The driving force of moisture movement is chemical potential. However, it is not always easy to relate chemical potential in wood to commonly observable variables, such as temperature and moisture content. Moisture in wood moves within the wood as liquid or vapour through several types of passageways, based on the nature of the driving force, (e.g. pressure or moisture gradient), and variations in wood structure, as explained in the next section on driving forces for moisture movement. These pathways consist of cavities of the vessels, fibres, ray cells, pit chambers and their pit membrane openings, intercellular spaces and transitory cell wall passageways. Movement of water takes place in these passageways in any direction, longitudinally in the cells, as well as laterally from cell to cell until it reaches the lateral drying surfaces of the wood. The higher longitudinal permeability of sapwood of hardwood is generally caused by the presence of vessels. The lateral permeability and transverse flow is often very low in hardwoods. The vessels in hardwoods are sometimes blocked by the presence of tyloses and/or by secreting gums and resins in some other species, as mentioned earlier. The presence of gum veins, the formation of which is often a result of natural protective response of trees to injury, is commonly observed on the surface of sawn boards of most eucalypts.
The British Lions were regular visitors to South Africa until the 1980s, and the less formally segregated colony long before that. They would alternate these tours with tours to Australia and/or New Zealand. In the years 1948–1980, the Lions made five tours to South Africa, more or less one for every decade, and half of their total ten tours in this period. Their first tour in the apartheid period was in 1955, seven years after the formal inauguration of apartheid. They made further tours in 1962, 1968, 1974 and one final one in 1980. The controversy caused by this matter meant that the Lions did not go back there until their 1997 tour when the South Africa team was ostensibly mixed. The Lions would have toured South Africa in 1986 if the regular schedule had been kept to, but in December 1985 the South African Rugby Board announced they would not be inviting the Lions to tour the following year. Political objections to South Africa's apartheid policies including a potential boycott of the 1986 Commonwealth Games and state of emergency in South Africa at the time lay behind this decision. The squad selected for an International Rugby Board centenary match was the closest thing to an official 1986 British Lions side. It was managed by Clive Rowlands and coached by Mick Doyle. The 21 players selected were issued with Lions' blazers and ties and considered to be official British Lions.
Sources: en.wikipedia.org
ribosome A macromolecular complex made of both RNA and protein which serves as the site of protein synthesis by translation. Ribosomes have two subunits, each of which consists of one or more strands of ribosomal RNA bound to various ribosomal proteins: the small subunit, which reads the messages encoded in messenger RNA molecules, and the large subunit, which links amino acids in sequence to form a polypeptide chain. Ribosomes are essential and ubiquitous in all cell types and are used by all known forms of life.
at IBM of methods to specifically produce single-walled carbon nanotubes by adding transition-metal catalysts to the carbon in an arc discharge. Thess et al. refined this catalytic method by vaporizing the carbon/transition-metal combination in a high-temperature furnace, which greatly improved the yield and purity of the SWNTs and made them widely available for characterization and application experiments. The arc discharge technique, well known to produce the famed Buckminsterfullerene, thus played a role in the discoveries of both multi- and single-wall nanotubes, extending the run of serendipitous discoveries relating to fullerenes. The discovery of nanotubes remains a contentious issue. Many believe that Iijima's report in 1991 is of particular importance because it brought carbon nanotubes into the awareness of the scientific community as a whole. In 2020, during an archaeological excavation of Keezhadi in Tamil Nadu, India, ~2600-year-old pottery was discovered whose coatings appear to contain carbon nanotubes. The robust mechanical properties of the nanotubes are partially why the coatings have lasted for so many years, say the scientists.
China provided a transcript of a 26 April press conference, indicating that an invitation to FDA investigators had been sent on 23 April but making no mention of banning melamine usage. On 3 May 2007, Chinese authorities detained Mao Lijun, general manager of the Xuzhou Anying Biologic Technology Development, one of the companies accused of exporting contaminated protein, on unspecified charges. On 29 May 2007, in actions not linked directly to the protein export scandal, Zheng Xiaoyu (郑筱萸), the former head of China's State Food and Drug Administration (SFDA), had been convicted of personally approving unproven and unsafe medicines after taking bribes from eight pharmaceutical companies totaling more than 6.49 million RMB (approximately 850,000 US dollars). These fraudulent approvals were estimated to have resulted in hundreds of patient deaths; consequently, Zheng was sentenced to death. It was also discovered during his eight years as head of the SFDA, Zheng had personally ordered the approval of more than 150,000 new medicines; by contrast, the U.S. FDA approves approximately 140 new medications per year. Most of those 150,000 medicines were manufactured by the eight pharmaceutical companies that bribed Zheng; one such unsafe medication, produced by the now-defunct Anhui Hua Yuan (华源) Company, resulted in 14 patient deaths and hundreds becoming permanently disabled. Zheng's former deputy was also convicted as an accomplice and given a two-year delayed death sentence.
The design of the flame ionization detector varies from manufacturer to manufacturer, but the principles are the same. Most commonly, the FID is attached to a gas chromatography system. The eluent exits the gas chromatography column (A) and enters the FID detector’s oven (B). The oven is needed to make sure that as soon as the eluent exits the column, it does not come out of the gaseous phase and deposit on the interface between the column and FID. This deposition would result in loss of eluent and errors in detection. As the eluent travels up the FID, it is first mixed with the hydrogen fuel (C) and then with the oxidant (D). The eluent/fuel/oxidant mixture continues to travel up to the nozzle head where a positive bias voltage exists. This positive bias helps to repel the oxidized carbon ions created by the flame (E) pyrolyzing the eluent. The ions (F) are repelled up toward the collector plates (G) which are connected to a very sensitive ammeter, which detects the ions hitting the plates, then feeds that signal to an amplifier, integrator, and display system(H). The products of the flame are finally vented out of the detector through the exhaust port (J).
In regions where Druze and Christians coexist, such as parts of Lebanon, Syria and Israel, the veneration of Mary often reflects a blend of traditions. Shared pilgrimage sites and mutual respect for places like the Church of Saidet et Tallé in Deir el Qamar, the Our Lady of Lebanon shrine in Harrisa, the Our Lady of Saidnaya Monastery in Saidnaya, and the Stella Maris Monastery in Haifa exemplify this. Historical records and writings by authors like Pierre-Marie Martin and Glenn Bowman show that Druze leaders and community members have historically shown deep reverence for Marian sites. They often sought her intercession before battles or during times of need, demonstrating a cultural and spiritual integration of Marian veneration into their religious practices. In Lebanon, the Virgin Mary serves as a unifying figure among Druze, Muslims, and Christians, fostering a sense of shared heritage and mutual respect. Nour Fara Haddad, a scholar of religious anthropology, states that this unity is particularly important in maintaining the social and cultural bonds between these communities.
Sources: en.wikipedia.org
=== Theories on amputation === In medieval Europe, amputation was done on limbs as a last resort when the limb could not be saved. For limbs that were dead or decaying, surgeons categorized them into two main categories: hot fire and cold fire. Hot fire (also called Gangraena) was the first stage of a decaying limb. A body part with hot fire was hot, swollen, and painful. If not treated, the limb would turn cold. Cold fire (also called Sphacelus) was the late stage of limb death, including death of the bone. Symptoms included loss of feeling, coldness, and black and blue coloring. With time, the fire would spread and eventually kill the patient. Followers of Galen considered hot and cold fire to be based on the humors and an imbalance of hot, wet, dry, and cold in the body. Followers of Paracelsus believed that hot and cold fire were a result of Mercury, sulfur, and salt. While different surgeons drew from different medical theories of the time, they also used their own experiences to determine the root cause of the fires. There was often debate on whether a particular patient had cold or hot fire, which led to disagreements on treatment methods. Treatment for hot fire often included burning or cutting out damaged flesh. If the symptoms were mild enough, the skin could sometimes be regrown. Treatment for cold fire included removing the dead flesh and likely amputation.
In the 1870s, the lack of a practical means of refrigerating peaches limited the markets available to Samuel Rumph, a Georgia peach grower. In 1875, he invented a refrigerated railcar and crates that allowed him to grow peaches on a very large scale and ship them to distant markets. He was the first to achieve this. His innovations created Georgia's fame for peaches, a crop now eclipsed economically by blueberries. Edwin Tobias Earl was born on a fruit ranch near Red Bluff, California, on May 30, 1858. His father was Joseph Earl, his mother Adelia Chaffee, and his brother was Guy Chaffee Earl. He started his career in fruit shipping. By 1886, he was President of the Earl Fruit Company. In 1890, he invented the refrigerator car to transport fruits to the East Coast of the United States. He established the Continental Fruit Express and invested US$2,000,000 in refrigerator cars. In 1901, he sold his refrigerator cars to Armour and Company of Chicago and became a millionaire. By the turn of the 20th century, manufactured ice became more common. The Pacific Fruit Express (PFE) - a joint venture between the Union Pacific and Southern Pacific railroads, with a fleet of 6,600 refrigerator cars built by the American Car and Foundry Company (ACF) - maintained seven natural harvesting facilities, and operated 18 artificial ice plants. Their largest plant (located in Roseville, California) produced 1,200 short tons (1,100 t) of ice daily, and Roseville's docks could accommodate up to 254 cars.
=== Molded graphene === In 2015, researchers from the University of Illinois at Urbana–Champaign (UIUC) developed a new approach for forming 3D shapes from flat, 2D sheets of graphene. A film of graphene that had been soaked in solvent to make it swell and become malleable was overlaid on an underlying substrate "former". The solvent evaporated over time, leaving behind a layer of graphene that had taken on the shape of the underlying structure. In this way, they were able to produce a range of relatively intricate micro-structured shapes. Features vary from 3.5 to 50 μm. Pure graphene and gold-decorated graphene were each successfully integrated with the substrate.
== Types == Organisms are broadly grouped into eukaryotes and prokaryotes. Eukaryotic cells possess a membrane-bound nucleus, and prokaryotic cells lack a nucleus but have a nucleoid region. Prokaryotes are single-celled organisms, whereas eukaryotes can be either single-celled or multicellular. Single-celled eukaryotes include microalgae such as diatoms, and some yeasts , species of fungi. Multicellular eukaryotes include all animals, and plants, most fungi, and some species of algae.
Sources: en.wikipedia.org
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.
It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.
WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.